PHB1 and breast cancer: We found that depletion of prohibitin from tamoxifen-sensitive breast cancer cells using siRNA prevented tamoxifen-induced cell cycle arrest, demonstrating a necessary role for prohibitin in estrogen antagonist-induced growth suppression (Wang et al. 2004).